NASDAQ: FENC FENNEC PHARMACEUTICALS INC. 10-K

Fennec settles Cipla litigation, extends exclusivity to 2033; revenue up 51% but loss widens

Filed March 27, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 26, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade FENC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.